Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Mark

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Mayo Clinic Proceedings|January 1, 1997
Effect of gender on angioplasty outcome: are we closer to the answer?K P Alexander, D B Mark
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic dataD B Mark, T A Simons
The American Journal of Managed Care|July 6, 1997
Quality improvement and clinical research: an important partnershipJ G Jollis, D B Mark
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2001
Rates of nucleotide substitution in sexual and anciently asexual rotifersD B Mark Welch, M S Meselson
The American Journal of Cardiology|September 1, 1985
Variant angina and spontaneous coronary artery dissectionD B Mark, Y Kong, R E Whalen
Circulation|September 1, 1996
Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness modelsE L Eisenstein, D B Mark, R M Califf
American Heart Journal|June 18, 1998
Outcomes and costs within a disease management program for advanced congestive heart failureK A Schulman, D B Mark, R M Califf
Statistics in Medicine|February 28, 1996
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsF E Harrell, K L Lee, D B Mark
American Heart Journal|April 30, 1999
Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapyR M Califf, D Stump, E J Topol, et al.
Kidney International|September 29, 2001
Severity of renal vascular disease predicts mortality in patients undergoing coronary angiographyP J Conlon, M A Little, K Pieper, et al.
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|January 1, 1997
Effect of gender on angioplasty outcome: are we closer to the answer?K P Alexander, D B Mark
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic dataD B Mark, T A Simons
The American Journal of Managed Care|July 6, 1997
Quality improvement and clinical research: an important partnershipJ G Jollis, D B Mark
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2001
Rates of nucleotide substitution in sexual and anciently asexual rotifersD B Mark Welch, M S Meselson
The American Journal of Cardiology|September 1, 1985
Variant angina and spontaneous coronary artery dissectionD B Mark, Y Kong, R E Whalen
Circulation|September 1, 1996
Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness modelsE L Eisenstein, D B Mark, R M Califf
American Heart Journal|June 18, 1998
Outcomes and costs within a disease management program for advanced congestive heart failureK A Schulman, D B Mark, R M Califf
Statistics in Medicine|February 28, 1996
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsF E Harrell, K L Lee, D B Mark
American Heart Journal|April 30, 1999
Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapyR M Califf, D Stump, E J Topol, et al.
Kidney International|September 29, 2001
Severity of renal vascular disease predicts mortality in patients undergoing coronary angiographyP J Conlon, M A Little, K Pieper, et al.
Pageof 18